ORIGINAL PAPER
Role of diffusion-weighted magnetic resonance imaging in the differentiation of benign and malignant pulmonary lesions
More details
Hide details
Submission date: 2018-07-22
Acceptance date: 2018-08-23
Publication date: 2018-12-20
Pol J Radiol, 2018; 83: 585-594
KEYWORDS
TOPICS
ABSTRACT
Purpose:
To evaluate the role of magnetic resonance (MRI) diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) measurement of solid and cystic pulmonary masses in differentiating benign from malignant lesions.
Material and methods:
The study included 41 patients with pulmonary masses, who underwent conventional MRI and DWI (b value 0, 500, and 1000 s/mm²) examinations with 1.5-T MRI. The diffusion signal and the mean ADC values of the solid and cystic lesions were obtained. Statistical analyses were performed with the Mann-Whitney U test (z), Pearson’s chi-square test, and receiver operating characteristic (ROC) analysis.
Results:
Thirty-three lesions were malignant, and eight lesions were benign. The malignant masses showed significantly higher signal intensity on DWI than benign masses (p = 0.006), and the mean ADC value of malignant solid lesions was significantly lower than that of benign lesions (p = 0.02). By ROC analysis, an ADC cut-off value of 1.4 × 10–3 mm2/s was considered the threshold value, and the sensitivity and specificity were 93.8% and 75%, respectively. There was no significant difference between the ADC value of the cystic parts inside the benign and the malignant lesions.
Conclusions:
Diffusion-weighted MRI and measurement of ADC value can significantly differentiate between solid benign and malignant pulmonary masses.
REFERENCES (12)
1.
Liu H, Liu Y, Yu T, et al. Usefulness of diffusion-weighted MR imaging in the evaluation of pulmonary lesions. Eur Radiol 2010; 20: 807-815.
2.
Satoh S, Kitazume Y, Ohdama S, et al. Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI? AJR Am J Roentgenol 2008; 191: 464-470.
3.
Wu L-M, Xu J, Hua J, et al. Can diffusion-weighted imaging be used as a reliable sequence in the detection of malignant pulmonary nodules and masses? Magn Reson Imaging 2013; 31: 235-246.
4.
Khalil A, Majlath M, Gounant V, et al. Contribution of magnetic resonance imaging in lung cancer imaging. Diagn Interv Imaging 2016; 97: 991-1002.
5.
Qi L, Zhang X, Tang L, et al. Using diffusion-weighted MR imaging for tumor detection in the collapsed lung: a preliminary study. Eur Radiol 2009; 9: 333-341.
6.
Bukte Y, Paksoy Y, Genc E, et al. Role of diffusion-weighted MR in differential diagnosis of intracranial cystic lesions. Clin Radiol 2005; 60: 375-383.
7.
Whanga J, Kolber M, Powell D, et al. Diffusion-weighted signal patterns of intracranial haemorrhage. Clin Radiol 2015; 70: 909-916.
8.
Uto T, Takehara Y, Nakamura Y, et al. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology 2009; 252: 247-254.
9.
Sabri Y, Kolta M, Khairy M. MR diffusion imaging in mediastinal masses the differentiation between benign and malignant lesions. Egyptian J Radiol Nucl Med 2017; 48: 569-580.
10.
Karaman Y, Ozgür A, Apaydın D. Role of diffusion-weighted magnetic resonance imaging in the differentiation of parotid gland tumors. Japanese Society for Oral and Maxillofacial Radiology and Springer Japan 2015.
11.
Abdel Razek A, Elmorsy A, Elshafey M, et al. Assessment of mediastinal tumors with diffusion weighted single shot echo planar MR imaging. J Mag Reson Imaging 2009; 30: 535-540.
12.
Gumustas S, Inan N, Sarisoy H, et al. Malignant versus benign mediastinal lesions: quantitative assessment with diffusion weighted MR imaging. Eur Radiol 2011; 21: 2255-2260.